A History of Progress and Innovation

Throughout the years, we have been committed to finding new ways to advance in our field while helping to improve the well-being of animals.
history
euStandards

European Standards

Our industrial facilities consist of several production units meeting the requirements of European Good Manufacturing Practices.

Our values

Our values are the strong foundation that guided us for decades, and the future ahead of us.
Research Jihane Handi working in the virology unit of the MCI Santé Animale laboratory in Mohammedia, Morocco. MCI is developing a bivalent Rift Valley Fever (RVF)/Lumpy Skin Disease (LSD) vaccine for cattle, and a trivalent Sheep and Goat Pox (SGP), Peste des Petits Ruminants (PPR), Rift Valley Fever (RVF) vaccine for sheep and goats to to establish solid herd immunity against RVF outbreaks through regular vaccination. The project is supported by the International Development Research Centre (IDRC). Mohammedia, Morocco. 26/03/2019.
Research technician Fakri Fatima ~Zohra working in the quality control unit of the MCI Santé Animale laboratory in Mohammedia, Morocco. MCI is developing a bivalent Rift Valley Fever (RVF)/Lumpy Skin Disease (LSD) vaccine for cattle, and a trivalent Sheep and Goat Pox (SGP), Peste des Petits Ruminants (PPR), Rift Valley Fever (RVF) vaccine for sheep and goats to to establish solid herd immunity against RVF outbreaks through regular vaccination. The project is supported by the International Development Research Centre (IDRC). Mohammedia, Morocco. 26/03/2019.

Research & Development

M.C.I. Santé Animale invests in the future and focuses its efforts on research and development.

Innovative Products

We offer innovative products such as polyvalent live vaccines, safe inactivated vaccines, and recombinant vaccines.
innovativeProducts_40

Ideally Positioned

Thanks to our strategic positioning and marketing expertise, we make our products within reach worldwide.

Subscribe to our newsletter